Literature DB >> 8238302

Alpha-chymotrypsin deregulation of the sodium-calcium exchanger in barnacle muscle cells.

R Espinosa-Tanguma1, J DeSantiago, H Rasgado-Flores.   

Abstract

To gain insight into the mechanism by which the protease alpha-chymotrypsin (alpha-chym) activates the Na-Ca exchanger in muscle cells we studied 1) the ability of this enzyme to remove the intracellular "catalytic" Ca2+ requirement for activation of all the modes of exchange mediated by the Na-Ca exchanger (i.e., Nao-Cai, Nai-Cao, Nao-Nai, and Cao-Cai, where the subscripts o and i represent extracellular and intracellular, respectively), and 2) the ability of certain monovalent cations to stimulate Cao-Cai exchange after activation of the exchanger by alpha-chym. Barnacle muscle cells were used as models because these cells are so large that they can be internally perfused and voltage clamped. The results show that alpha-chym produces a highly activated Na-Ca exchanger able to operate in all its modes of exchange independently of catalytic Cai. The concentration-dependent effect of alpha-chym was biphasic; maximal activation occurred at 0.5 mg alpha-chym/ml perfusate for 20 min of perfusion at a perfusion rate of 2.5 microliters/min. The results are discussed in terms of the possible effects of alpha-chym on the kinetic modulation of the exchanger.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238302     DOI: 10.1152/ajpcell.1993.265.4.C1118

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Inhibitory effect of aprindine on Na+/Ca2+ exchange current in guinea-pig cardiac ventricular myocytes.

Authors:  Yasuhide Watanabe; Takahiro Iwamoto; Munekazu Shigekawa; Junko Kimura
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

2.  Acute inhibitory effect of dronedarone, a noniodinated benzofuran analogue of amiodarone, on Na+/Ca2+ exchange current in guinea pig cardiac ventricular myocytes.

Authors:  Yasuhide Watanabe; Junko Kimura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-08       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.